WHO ICTRP trial
The efficacy of steroid therapy in the patient with Fukuyama congenital muscular…
JPRN-UMIN000020715 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000020715 |
|---|---|
| Public title | The efficacy of steroid therapy in the patient with Fukuyama congenital muscular dystrophy |
| Scientific title | The efficacy of steroid therapy in the patient with Fukuyama congenital muscular dystrophy - The efficacy of steroid therapy in the patient with Fukuyama congenital muscular dystrophy |
| Primary sponsor | The department of Pediatrics, Tokyo Women's Medical University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Fukuyama congenital muscular dystrophy |
| Interventions | Predonisolone (PSL) is administered at a dose of0.5mg/kg on alternate day (0.25mg/kg/d) for the first 2 weeks. Subsequently, the dose of PSL is increased to 1.0mg/kg on alternate days (0.5mg/kg/d) . Three months after the start of therapy… |
| Registration date | Jan 2, 2016 |
| Target size | 14 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: